Author Archives: donttradeourlivesaway

[Financial Times] Will poor countries get the coronavirus treatments they need?

Andrew Jack writes for the Financial Times here: https://www.ft.com/content/cd522abc-8aeb-11ea-a109-483c62d17528 Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies As the EU launched efforts this week to raise €7.5bn from donors … Continue reading

Posted in Uncategorized | Leave a comment

Letter from US lawmakers on public funding of Remdesivir to US HHS Secretary Azar

U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, and Rep. Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, urge Secretary Azar to release information about the extent … Continue reading

Posted in Uncategorized | Leave a comment

[Follow the Money] Roche releases recipe, after European Commission considers intervention due to lack of coronavirus tests

Read full article here: https://www.ftm.nl/artikelen/roche-releases-recipe-after-public-pressure-while-european-commission-considers-intervention-due-to-coronavirus-test Pharmaceutical company Roche announced Friday afternoon that it will release the recipe for its lysis buffer if Dutch laboratories ask for it. Earlier today Follow the Money revealed that the European Commission was exploring options … Continue reading

Posted in Uncategorized | Leave a comment

[The Times of India] United we will be saved: Global leadership is needed to push pharma solutions and distribute them at affordable prices

Ujal Bhatia, India’s former Ambassador of India to the WTO writes on the need for a Global leadership to push Pharmaceutical solutions and distribute them at affordable prices. Read full article here: https://timesofindia.indiatimes.com/blogs/toi-edit-page/united-we-will-be-saved-global-leadership-is-needed-to-push-pharma-solutions-and-distribute-them-at-affordable-prices/ *** Global pandemics like Covid-19 require a … Continue reading

Posted in Uncategorized | Leave a comment

[South Centre] Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock

South Centre Policy Brief by Dr. Dr. German Velasquez on Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock The unprecedented global health crisis caused by the coronavirus COVID-19pandemic, during the first quarter of 2020, brings back with … Continue reading

Posted in Uncategorized | Leave a comment

Drug Companies are Running Scared – Let’s Make Them Run Faster

First published on Info Justice: http://infojustice.org/archives/42209 Big Pharma notched a regrettable victory in the early days of the COVID-19 response when it  successfully blocked an enforceable reasonable-pricing clause from inclusion in the first $8.3 billion emergency spending bill.  Although the … Continue reading

Posted in Uncategorized | Leave a comment

Open Appeal of Public Organizations in the Field of Improving Access to Medicines to the Governments of Eastern Europe and Central Asia (EECA)

In light of the evolving coronavirus (COVID-19) pandemic, the governments are taking unprecedented infection prevention and control measures. One of the most important areas of work is providing people affected by COVID-19 with medical therapy, diagnostics devices and medical equipment. … Continue reading

Posted in Uncategorized | Leave a comment